DaJiMed | Back from ISBT Kuala Lumpur 2026

DaJiMed | Back from ISBT Kuala Lumpur 2026  

The 2026 ISBT Kuala Lumpur Congress has come to a perfect conclusion.

Over the course of the exhibition, we were honored to reconnect with our long-term partners and friends from all over the world. It was incredibly rewarding to catch up face-to-face, review our steady cooperation progress, and share insights into ongoing market development.

Meanwhile, we were delighted to meet numerous new industry professionals and potential partners at the event. We had in-depth communications regarding regional market demands, technical challenges, and future development trends in transfusion medicine and blood filtration. 

Every sincere conversation, professional exchange, and valuable suggestion has inspired us deeply. It further clarified the diversified demands of different regions and helped us optimize our product solutions, technical support, and localized services for global markets.

We sincerely appreciate every visit, trust, and collaboration opportunity from our partners.

Although the exhibition has ended, our global cooperation journey continues. DAJIMED will keep focusing on product innovation, quality improvement and professional after-sales support, striving to deliver safer, more efficient and reliable leukocyte reduction filtration solutions for blood banks and transfusion institutions worldwide.

Looking forward to growing steadily and creating greater value with all our partners in the future.